| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-131 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17f62283cd071a6fb31536de942866c4 |
| publicationDate |
1997-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5602143-A |
| titleOfInvention |
Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors |
| abstract |
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains as the active ingredient one or more compounds having guanylate cyclase inhibition activity. Examples of guanylate cyclase inhibitors utilized in the pharmaceutical composition and method of treatment are: <IMAGE> and pharmaceutically acceptable salts thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011034386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004192660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7825092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009317436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7846900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008268537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003008919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002184003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009170196-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004110729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004102420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008039394-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6455589-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8148114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10184942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008214437-A1 |
| priorityDate |
1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |